Download
https://www.ndtvprofit.com/business/aurobindo-pharma-arm-extends-negotiations-deadline-with-msd-for-contract-manufacturing-operations?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has extended the deadline for negotiations with Merck Sharp & Dohme Singapore for contract manufacturing operations for biologicals until May 2024.
Share